Avansert søk
GSK in focus
Relevante brosjyrer
Last ned i pdf-format
Lungekreft
Lungekreft er den nest hyppigste kreftformen for menn og den tredje hyppigste kreftformen hos kvinner.
Studieresymé
Phase III Trial Comparing Supportive Care Alone With Supportive Care With Oral Topotecan in Patients With Relapsed Small-Cell Lung Cancer. Journal of Clinical Oncology, Volume 24, Number 34, December 1 2006
Phase III Study of Oral Compared With Intravenous Topotecan As Second-Line Therapy in Small-Cell Lung Cancer. Journal of Clinical Oncology, Volume 25, Number 15, May 20, 2007
Topotecan Versus Cyclophosphamide, Doxorubicin and Vincristine for the Treatment of Recurrent Small-Cell Lung Cancer. Journal of Clinical Oncology, Volume 17, Number 2, February, 1999
Referanser
- SPC Hycamtin
- Kreftregisteret.no
- O'Brian. Phase III Trial Comparing Supportive Care Alone With Supportive Care With Oral Topotecan in Patients With Relapsed Small-Cell Lung Cancer. Journal of Clinical Oncology, Volume 24, Number 34, December 1 2006
- Eckardt. Phase III Study of Oral Compared With Intravenous Topotecan As Second-Line Therapy in Small-Cell Lung Cancer. Journal of Clinical Oncology, Volume 25, Number 15, May 20, 2007
- von Pawel. Topotecan Versus Cyclophosphamide, Doxorubicin and Vincristine for the Treatment of Recurrent Small-Cell Lung Cancer. Journal of Clinical Oncology, Volume 17, Number 2, February, 1999
Brosjyrer
 |
Doseringsanbefalinger |
 |
Hvordan bruke Hycamtin® (topotekan) |
 |
Et pusterom Godkjent som monotepapi ved behandling av residiverende SCLC |
